Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.

<h4>Background</h4>Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogeni...

Full description

Saved in:
Bibliographic Details
Main Authors: Margherita Neri, Claudio Maderna, Daniela Ferrari, Chiara Cavazzin, Angelo L Vescovi, Angela Gritti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-04-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010145&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849734992411754496
author Margherita Neri
Claudio Maderna
Daniela Ferrari
Chiara Cavazzin
Angelo L Vescovi
Angela Gritti
author_facet Margherita Neri
Claudio Maderna
Daniela Ferrari
Chiara Cavazzin
Angelo L Vescovi
Angela Gritti
author_sort Margherita Neri
collection DOAJ
description <h4>Background</h4>Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogenicity might restrict their use in clinical applications. Virtually unlimited numbers of oligodendroglial cells could be generated from long-term self-renewing human (h)-derived neural stem cells (hNSC). However, robust oligodendrocyte production from hNSC has not been reported so far, indicating the need for improved understanding of the molecular and environmental signals controlling hNSC progression through the oligodendroglial lineage. The aim of this work was to obtain enriched and renewable cultures of hNSC-derived oligodendroglial cells by means of epigenetic manipulation.<h4>Methodology/principal findings</h4>We report here the generation of large numbers of hNSC-derived oligodendroglial cells by concurrent/sequential in vitro exposure to combinations of growth factors (FGF2, PDGF-AA), neurotrophins (NT3) and hormones (T3). In particular, the combination FGF2+NT3+PDGF-AA resulted in the maintenance and enrichment of an oligodendroglial cell population displaying immature phenotype (i.e., proliferation capacity and expression of PDGFRalpha, Olig1 and Sox10), limited self-renewal and increased migratory activity in vitro. These cells generate large numbers of oligodendroglial progeny at the early stages of maturation, both in vitro and after transplantation in models of CNS demyelination.<h4>Conclusions/significance</h4>We describe a reliable method to generate large numbers of oligodendrocytes from a renewable source of somatic, non-immortalized NSC from the human foetal brain. We also provide insights on the mechanisms underlying the pro-oligodendrogenic effect of the treatments in vitro and discuss potential issues responsible for the limited myelinating capacity shown by hNSC-derived oligodendrocytes in vivo.
format Article
id doaj-art-e6dfa302c88c49249f0cb97cc92d668b
institution DOAJ
issn 1932-6203
language English
publishDate 2010-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e6dfa302c88c49249f0cb97cc92d668b2025-08-20T03:07:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-04-0154e1014510.1371/journal.pone.0010145Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.Margherita NeriClaudio MadernaDaniela FerrariChiara CavazzinAngelo L VescoviAngela Gritti<h4>Background</h4>Cell-based therapy holds great promises for demyelinating diseases. Human-derived fetal and adult oligodendrocyte progenitors (OPC) gave encouraging results in experimental models of dysmyelination but their limited proliferation in vitro and their potential immunogenicity might restrict their use in clinical applications. Virtually unlimited numbers of oligodendroglial cells could be generated from long-term self-renewing human (h)-derived neural stem cells (hNSC). However, robust oligodendrocyte production from hNSC has not been reported so far, indicating the need for improved understanding of the molecular and environmental signals controlling hNSC progression through the oligodendroglial lineage. The aim of this work was to obtain enriched and renewable cultures of hNSC-derived oligodendroglial cells by means of epigenetic manipulation.<h4>Methodology/principal findings</h4>We report here the generation of large numbers of hNSC-derived oligodendroglial cells by concurrent/sequential in vitro exposure to combinations of growth factors (FGF2, PDGF-AA), neurotrophins (NT3) and hormones (T3). In particular, the combination FGF2+NT3+PDGF-AA resulted in the maintenance and enrichment of an oligodendroglial cell population displaying immature phenotype (i.e., proliferation capacity and expression of PDGFRalpha, Olig1 and Sox10), limited self-renewal and increased migratory activity in vitro. These cells generate large numbers of oligodendroglial progeny at the early stages of maturation, both in vitro and after transplantation in models of CNS demyelination.<h4>Conclusions/significance</h4>We describe a reliable method to generate large numbers of oligodendrocytes from a renewable source of somatic, non-immortalized NSC from the human foetal brain. We also provide insights on the mechanisms underlying the pro-oligodendrogenic effect of the treatments in vitro and discuss potential issues responsible for the limited myelinating capacity shown by hNSC-derived oligodendrocytes in vivo.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010145&type=printable
spellingShingle Margherita Neri
Claudio Maderna
Daniela Ferrari
Chiara Cavazzin
Angelo L Vescovi
Angela Gritti
Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
PLoS ONE
title Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
title_full Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
title_fullStr Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
title_full_unstemmed Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
title_short Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice.
title_sort robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0010145&type=printable
work_keys_str_mv AT margheritaneri robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice
AT claudiomaderna robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice
AT danielaferrari robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice
AT chiaracavazzin robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice
AT angelolvescovi robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice
AT angelagritti robustgenerationofoligodendrocyteprogenitorsfromhumanneuralstemcellsandengraftmentinexperimentaldemyelinationmodelsinmice